<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03695900</url>
  </required_header>
  <id_info>
    <org_study_id>20180536</org_study_id>
    <nct_id>NCT03695900</nct_id>
  </id_info>
  <brief_title>Arterial Oxygen Saturation on Ventilatory Stability in Extremely Premature Infants</brief_title>
  <official_title>Impact of Arterial Oxygen Saturation Range on Ventilatory Stability in Extremely Premature Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Gerber Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective crossover study to compare the within-subject effect of the two target
      ranges of arterial oxygen saturation (SpO2), both within the clinically recommended range of
      90- 95%. The specific objective of this study to evaluate the impact of targeting SpO2 within
      93-95% compared to the 90-92% range on ventilatory stability in premature infants of 23-29
      weeks gestational age (GA).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Anticipated">October 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>This is a prospective crossover study to compare the within-subject effect of the two target ranges of arterial oxygen saturation (SpO2, 93-95% vs 90-92%) on ventilatory stability in premature infants.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ventilatory stability by frequency of central apnea</measure>
    <time_frame>2 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>ventilatory stability by frequency of obstructive apnea</measure>
    <time_frame>2 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>ventilatory stability by density of periodic breathing</measure>
    <time_frame>2 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>ventilatory stability by time series of inter-breath intervals</measure>
    <time_frame>2 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>oxygenation stability by frequency of intermittent hypoxemia episodes</measure>
    <time_frame>2 hours</time_frame>
    <description>frequency of episodes with SpO2 &lt; 80%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>frequency of bradycardia episodes</measure>
    <time_frame>2 hours</time_frame>
    <description>frequency of episodes with HR &lt; 100 bpm</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Apnea of Prematurity</condition>
  <condition>Desaturation of Blood</condition>
  <condition>Central Apnea</condition>
  <condition>Periodic Breathing</condition>
  <condition>Obstructive Apnea of Newborn</condition>
  <arm_group>
    <arm_group_label>Targeting SpO2 at 93-95% followed by targeting at 90-92%</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>FiO2 adjusted to keep basal SpO2 at target range of 93-95% for 2 hours, followed by FiO2 adjusted to keep basal SpO2 at target range of 90-92% for 2 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Targeting SpO2 at 90-92% followed by targeting at 93-95%</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>FiO2 adjusted to keep basal SpO2 at target range of 90-92% for 2 hours, followed by FiO2 adjusted to keep basal SpO2 at target range of 93-95% for 2 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Targeting SpO2 at 93-95%</intervention_name>
    <description>FiO2 adjusted to keep basal SpO2 at target range of 93-95% for 2 hours</description>
    <arm_group_label>Targeting SpO2 at 90-92% followed by targeting at 93-95%</arm_group_label>
    <arm_group_label>Targeting SpO2 at 93-95% followed by targeting at 90-92%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Targeting SpO2 at 90-92%</intervention_name>
    <description>FiO2 adjusted to keep basal SpO2 at target range of 90-92% for 2 hours.</description>
    <arm_group_label>Targeting SpO2 at 90-92% followed by targeting at 93-95%</arm_group_label>
    <arm_group_label>Targeting SpO2 at 93-95% followed by targeting at 90-92%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  23 0/7- 29 6/7 weeks gestational age

          -  Postnatal age ≥ 14 days

          -  Requiring FiO2 ≥ 0.25 to keep SpO2 90-95%

          -  Parental informed consent

        Exclusion Criteria:

          -  Severe congenital anomalies that may affect pulmonary or neurosensory development

          -  Severe CNS pathology that may alter respiratory control function
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nelson Claure, MSc, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eduardo Bancalari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Deepak Jain, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Waleed Kurtom, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jackson Health System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alini Schott, RN</last_name>
    <phone>3055856404</phone>
    <email>abs225@miami.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ana Aguilar, RRT</last_name>
    <phone>3055856404</phone>
    <email>aca135@miami.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Holtz Children's Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alini Schott, RN</last_name>
      <phone>305-585-6404</phone>
      <email>abs225@miami.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ana Aguilar, RRT</last_name>
      <email>aca135@miami.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Nelson Claure, MSC, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eduardo Bancalari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Deepak Jain, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Waleed Kurtom, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>October 2, 2018</study_first_submitted>
  <study_first_submitted_qc>October 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2018</study_first_posted>
  <last_update_submitted>January 2, 2020</last_update_submitted>
  <last_update_submitted_qc>January 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Nelson Claure</investigator_full_name>
    <investigator_title>Associate Professor of Pediatrics</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Sleep Apnea, Central</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

